Copyright
©The Author(s) 2018.
World J Gastroenterol. Sep 21, 2018; 24(35): 4036-4053
Published online Sep 21, 2018. doi: 10.3748/wjg.v24.i35.4036
Published online Sep 21, 2018. doi: 10.3748/wjg.v24.i35.4036
Figure 1 Chronic 2, 4, 6-trinitrobenzenesulfonic acid-induced colitis models of wild-type and transient receptor potential ankyrin 1-knockout mice.
Chronic colitis was induced by weekly intrarectal injection of TNBS for six weeks. Immediately after the final TNBS treatment, a DKT enema was administered daily for one week. A: schematic presentation of TNBS injection and DKT enema; B: Hematoxylin–eosin (HE)- and Masson's trichrome (MT)-stained tissues from the vehicle control, TNBS and TNBS + DKT groups of WT and TRPA1-/- mice. TNBS: 2, 4, 6-trinitrobenzenesulfonic acid; WT: Wild-type; TRPA1: Transient receptor potential ankyrin 1; TRPA1-/-: Transient receptor potential ankyrin 1-knockout; DKT: Daikenchuto; HE: Hematoxylin-eosin; MT: Masson's trichrome.
- Citation: Hiraishi K, Kurahara LH, Sumiyoshi M, Hu YP, Koga K, Onitsuka M, Kojima D, Yue L, Takedatsu H, Jian YW, Inoue R. Daikenchuto (Da-Jian-Zhong-Tang) ameliorates intestinal fibrosis by activating myofibroblast transient receptor potential ankyrin 1 channel. World J Gastroenterol 2018; 24(35): 4036-4053
- URL: https://www.wjgnet.com/1007-9327/full/v24/i35/4036.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i35.4036